Home | Survey | Payment| Talks & Presentations | Job Opportunities
Journals   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Infectious Disease Information
1007-8134
2016 Issue 2
ying jie man xing bing xing gan yan zhi liao de chun tian daas shi dai de dao lai
chuan ran bing xin xi bian ji bu ;
..............page:Ⅰ
Optimal management and outlook for antiviral therapy of chronic HBV infection
ZHANG Kai;,LIU Yan;,XU Dong-ping;,LIN Shu-mei;
..............page:65-70,76
New strategies for prevention and treatment of hepatitis C in China
DOU Xiao-guang;,DING Yang;
..............page:71-72,100
Forty-eight weeks of combination therapy with interferon and nucleos(t)ide analogues for HBeAg-positive chronic hepatitis B
CAO Zhen-huan;,LIU Ya-li;,LU Jun-feng;,MA Li-na;,JIN Yi;,HE Zhi-min;,CHEN Xin-yue;
..............page:77-80,88
Early efficacy and safety of direct-acting antiviral agents for the treatment of cirrhotic patients with hepatitis C
AN Zi-ying;,SHENG Qiu-ju;,ZHANG Chong;,BAI Han;,WANG Jing-yan;,DOU Xiao-guang;,DING Yang;
..............page:81-84,96
Protective effect of granulocyte-colony stimulating factor on acute injury of human fetal hepatocytes
SUN Zi-jian;,CHEN Jing;,XIA Yan-heng;,LIU Xiao-yan;,SU Hai-bin;,YANG Hao-zhen;,XU Xiang;,HU Jin-hua;
..............page:89-91
Expressions of programmed death 1, programmed death ligand-1 and nerve growth factor in liver cancer tissues and their significance
YANG Shuo;,ZHANG Yun-hui;,SUN Yan-ling;,ZHOU Zhi-ping;,SHI Ming;
..............page:92-96
Clinical features and causes of death of 191 AIDS patients
WANG Zhen-yan;,SHEN Yin-zhong;,LIU Li;,ZHANG Ren-fang;,LU Hong-zhou;
..............page:97-100
gan rao su zhi liao jia zhuang xian ji su di kang zong he zheng he bing man xing bing xing gan yan 1 li
kang yao jie ;, wang ye ;, wang zuo ;, zhang zuo zuo ;, zuo hua ;
..............page:106-108
Advances and new strategies for the treatment of chronic hepatitis B
CHENG QI;,SHI Guang-feng;
..............page:109-112
Research progress of HBV preS/S gene mutations
LU Shan-shan;,XU Dong-ping;,LI Jin;
..............page:112-116
Research of HCV variants resistant to direct-acting antiviral agents
CHEN Jian-hong;,XU Xiao-yuan;
..............page:116-120
Metabolism and drug interactions of direct-acting antiviral agents for hepatitis C
ZHOU Shuang-nan;,ZHANG Min;
..............page:121-125